Details for New Drug Application (NDA): 021411
✉ Email this page to a colleague
NDA 021411 describes STRATTERA, which is a drug marketed by Lilly and is included in one NDA. It is available from one supplier. Additional details are available on the STRATTERA profile page.
The generic ingredient in STRATTERA is atomoxetine hydrochloride. There are sixteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the atomoxetine hydrochloride profile page.
The generic ingredient in STRATTERA is atomoxetine hydrochloride. There are sixteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the atomoxetine hydrochloride profile page.
Summary for 021411
| Tradename: | STRATTERA |
| Applicant: | Lilly |
| Ingredient: | atomoxetine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 021411
| Mechanism of Action | Norepinephrine Uptake Inhibitors |
Medical Subject Heading (MeSH) Categories for 021411
Suppliers and Packaging for NDA: 021411
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| STRATTERA | atomoxetine hydrochloride | CAPSULE;ORAL | 021411 | NDA | Eli Lilly and Company | 0002-3227 | 0002-3227-30 | 30 CAPSULE in 1 BOTTLE (0002-3227-30) |
| STRATTERA | atomoxetine hydrochloride | CAPSULE;ORAL | 021411 | NDA | Eli Lilly and Company | 0002-3228 | 0002-3228-30 | 30 CAPSULE in 1 BOTTLE (0002-3228-30) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 5MG BASE | ||||
| Approval Date: | Nov 26, 2002 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 10MG BASE | ||||
| Approval Date: | Nov 26, 2002 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 18MG BASE | ||||
| Approval Date: | Nov 26, 2002 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
